894P AXEL: AXitinib-avELumab combination in recurrent or metastatic (RM) nasopharyngeal cancer (NPC)
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.08.955
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3
Papers
0
Citations
0
h-index
0
i10-index
B.B.Y. Ma is an academic researcher from Chinese University of Hong Kong. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Mesenchymal stem cell research & Angiogenesis and VEGF in Cancer.
Click to start Chat